We. Katz et al., QUANTITATIVE-EVALUATION OF THE SEGMENTAL LEFT-VENTRICULAR RESPONSE TODOBUTAMINE STRESS BY TISSUE DOPPLER-ECHOCARDIOGRAPHY, The American journal of cardiology, 79(8), 1997, pp. 1036-1042
Tissue Doppler imaging displays color-coded myocardial velocity on-lin
e and has potential to objectively quantify regional left ventricular
function. Sixty patients, aged 56 +/- 10 years, were studied to determ
ine the normal and abnormal segmental endocardial velocity response to
dobutamine stress, and the sensitivity, specificity, and accuracy of
tissue Doppler imaging for detecting abnormal wall motion at peak stre
ss as defined by routine visual interpretation, Separate 2-dimensional
routine gray scale and color tissue Doppler image sets were acquired
at rest and peak dobutamine stress in a digital cineloop format, Routi
ne wall motion interpretation from gray scale images and color-coded p
eak systolic endocardial velocity from tissue Doppler images were dete
rmined independently Twenty-two patients who reached their target hear
t rate and had normal wall motion at peak stress served as a control g
roup, There were 19 patients who had wall motion abnormalities at peak
stress, Segmental peak endocardial velocities increased significantly
in all segments in the control group. Endocardial velocity was signif
icantly Bower at peak stress in the pooled abnormal segments than in t
he pooled normal segments: 3.1 +/- 1,2 versus 7.2 +/- 1.9 cm/s, respec
tively (p < 0,05 vs normal control). However, the velocity response of
abnormal apical segments could not be distinguished from normal contr
ols by tissue Doppler imaging. Excluding apical segments, a peak veloc
ity of less than or equal to 5.5 cm/s with peak stress had an average
sensitivity of 96%, specificity of 81%, and accuracy of 86% for identi
fying abnormal segments at peak stress as defined by routine 2-dimensi
onal criteria. Tissue Doppler imaging has the potential to quantify re
gional left ventricular function during dobutamine stress. (C) 1997 by
Excerpta Medica, Inc.